http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101415174-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-322 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-83 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-423 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-423 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12 |
| filingDate | 2012-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101415174-B1 |
| titleOfInvention | Novel benzoxazol derivatives or pharmaceutically acceptable salts thereof, process for the preparation thereof and pharmaceutical composition for prevention or treatment of RAGE receptor related diseases containing the same as an active ingredient |
| abstract | The present invention relates to a novel benzoxazole-based derivative or a pharmaceutically acceptable salt thereof, a process for producing the same, and a pharmaceutical composition for preventing or treating RAGE receptor-related diseases comprising the same. The benzoxazole derivatives of the present invention antagonize RAGE receptors, and thus can inhibit the RAGE receptor-related diseases such as erectile dysfunction, renal failure, lupus nephritis, tumor invasion and metastasis, inflammation, nephropathy, increased vascular permeability, arteriosclerosis and retinopathy Etc., and amyloidosis including Alzheimer's disease, typical AL amyloidosis and AA amyloidosis, and the like. |
| priorityDate | 2012-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 877.